EP Wealth Advisors LLC grew its position in The Cigna Group (NYSE:CI - Free Report) by 98.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 10,767 shares of the health services provider's stock after buying an additional 5,333 shares during the period. EP Wealth Advisors LLC's holdings in The Cigna Group were worth $3,730,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. FMR LLC increased its holdings in The Cigna Group by 2.0% during the third quarter. FMR LLC now owns 14,230,397 shares of the health services provider's stock valued at $4,929,978,000 after buying an additional 279,880 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in The Cigna Group by 1.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 11,054,958 shares of the health services provider's stock valued at $3,829,880,000 after purchasing an additional 130,048 shares during the period. Parnassus Investments LLC grew its holdings in The Cigna Group by 2.1% during the 3rd quarter. Parnassus Investments LLC now owns 2,922,121 shares of the health services provider's stock valued at $1,012,340,000 after purchasing an additional 59,011 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of The Cigna Group by 6.1% during the second quarter. Dimensional Fund Advisors LP now owns 2,628,807 shares of the health services provider's stock worth $869,078,000 after purchasing an additional 150,765 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of The Cigna Group by 2.1% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,168,959 shares of the health services provider's stock valued at $751,414,000 after purchasing an additional 44,810 shares during the period. 86.99% of the stock is owned by institutional investors.
The Cigna Group Stock Up 0.4 %
NYSE CI traded up $1.39 on Monday, hitting $319.20. 2,146,077 shares of the stock were exchanged, compared to its average volume of 1,546,699. The Cigna Group has a fifty-two week low of $288.88 and a fifty-two week high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The company has a market cap of $88.79 billion, a PE ratio of 30.11, a PEG ratio of 0.96 and a beta of 0.50. The company has a 50-day moving average price of $330.47 and a 200-day moving average price of $337.91.
The Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping the consensus estimate of $7.22 by $0.29. The business had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business's quarterly revenue was up 29.8% on a year-over-year basis. During the same quarter last year, the company earned $6.77 EPS. Sell-side analysts anticipate that The Cigna Group will post 28.49 EPS for the current fiscal year.
The Cigna Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be issued a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a dividend yield of 1.75%. The ex-dividend date is Wednesday, December 4th. The Cigna Group's payout ratio is 52.83%.
Wall Street Analyst Weigh In
CI has been the subject of several analyst reports. JPMorgan Chase & Co. increased their price target on shares of The Cigna Group from $435.00 to $438.00 and gave the company an "overweight" rating in a research report on Wednesday, August 21st. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $400.00 price target on shares of The Cigna Group in a report on Wednesday, October 23rd. Royal Bank of Canada lowered their price objective on The Cigna Group from $384.00 to $377.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Deutsche Bank Aktiengesellschaft lowered their price target on shares of The Cigna Group from $398.00 to $394.00 and set a "buy" rating on the stock in a research report on Monday, November 4th. Finally, Piper Sandler reissued an "overweight" rating and set a $394.00 price target (up previously from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $394.64.
Get Our Latest Report on The Cigna Group
The Cigna Group Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.